Dr Reddys Laboratories (RDY) Current Assets (2009 - 2026)
Dr Reddys Laboratories' Current Assets was $3.16 billion in the quarter ended Jun 30, 2026, up 0.3% from $3.15 billion a year earlier but down 4.3% from the prior quarter.
Dr Reddys Laboratories (RDY) Current Assets (2009 - 2026) Analysis & Trends
As of Mar 31, 2026, Current Assets at Dr Reddys Laboratories came in at $3.22 billion, up 9.9% from the prior year.
- Current Assets shows a five-year compound annual growth rate of 9.7% (years ended Mar 2021 to Mar 2026).
- In earlier years, Current Assets was $2.93 billion in the year ended Mar 31, 2025 (-1.6%), $2.98 billion in the year ended Mar 31, 2024 (+18.2%), $2.52 billion in the year ended Mar 31, 2023 (+5.0%) and $2.4 billion in the year ended Mar 31, 2022 (+18.3%).
- Quarterly Current Assets has moved between $2.2 billion (the quarter ended Sep 30, 2022) and $3.34 billion (the quarter ended Dec 31, 2025) over five years.
- Compared with a year earlier, Current Assets has increased for four straight quarters, with growth averaging 5.7% over the last eight quarters.
- The best year-over-year quarter for Current Assets over five years was the quarter ended Jun 30, 2024 (growth of 26.1%); the worst was the quarter ended Mar 31, 2025 (a decline of 3.3%).
- Per Business Quant data, RDY's Current Assets in the three quarters before the quarter ended Jun 30, 2026 was $3.3 billion (quarter ended Mar 31, 2026), $3.34 billion (quarter ended Dec 31, 2025) and $3.2 billion (quarter ended Sep 30, 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 59.77 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 33.67 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 36.68 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 27.35 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 27.97 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 34.96 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 13.95 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 41.36 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 12.54 Bn |
| 10 | Dr Reddys Laboratories | 10.44 Bn | 9.62 Bn | 396.53 Mn | 3.16 Bn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 3.16 Bn |
| Mar 31, 2026 | 3.30 Bn |
| Dec 31, 2025 | 3.34 Bn |
| Sep 30, 2025 | 3.20 Bn |
| Jun 30, 2025 | 3.15 Bn |
| Mar 31, 2025 | 2.89 Bn |
| Dec 31, 2024 | 3.00 Bn |
| Sep 30, 2024 | 2.96 Bn |
| Jun 30, 2024 | 3.23 Bn |
| Mar 31, 2024 | 2.99 Bn |
| Dec 31, 2023 | 2.86 Bn |
| Sep 30, 2023 | 2.63 Bn |
| Jun 30, 2023 | 2.56 Bn |
| Mar 31, 2023 | 2.48 Bn |
| Dec 31, 2022 | 2.37 Bn |
| Sep 30, 2022 | 2.20 Bn |
| Jun 30, 2022 | 2.33 Bn |
| Mar 31, 2022 | 2.42 Bn |
| Dec 31, 2021 | 2.23 Bn |
| Sep 30, 2021 | 2.20 Bn |
Dr Reddys Laboratories Current Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=current-assets&ticker=RDY&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "current-assets", "ticker": "RDY", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=current-assets&ticker=RDY&period=max&api_key=YOUR_API_KEY");
const data = await res.json();